Sensus Healthcare IncSRTS
Price$2.95Intrinsic value$4.5053% above price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
Analyst Coverage
4analysts covering
Consensus: PositiveAs of 18 Aug 2026
FY EPS (est.)
-$0.40next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Global Installed Base (SRT Units) Quarterly965
Quarterly SRT System Shipments Quarterly14.0
Active Fair Deal Agreement (FDA) Sites Quarterly18.0
Watch Items
  • Reimbursement Code Transition ImpactTrigger: Physician adoption rates and sales cycle duration following the January 1, 2026 CPT code updates.Action: Monitor quarterly system shipments and direct sales pipeline conversion to evaluate if the 300% increase in the per-fraction delivery code translates into shorter sales cycles.
  • Customer Base DiversificationTrigger: Contribution of the historically largest customer to total revenue.Action: Track the proportion of direct sales and placements made to new, diversified accounts to ensure the company successfully mitigates its historical customer concentration risk.
  • Fair Deal Agreement (FDA) and Rental PlacementsTrigger: FDA pending activations converting to active sites.Action: Evaluate the sequential growth of deferred revenue and recurring revenue streams as more systems are placed under revenue-share and rental structures rather than direct sales.
Sign in / Sign up to read more

Research as of 19 Jun 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.